Cargando…
Sex differences in time course and diagnostic accuracy of GFAP and UCH-L1 in trauma patients with mild traumatic brain injury
Glial Fibrillary Acidic Protein (GFAP) and Ubiquitin C-terminal hydrolase (UCH-L1) have been FDA-approved for clinical use in mild and moderate traumatic brain injury (TBI). Understanding sex differences in their diagnostic accuracy over time will help inform clinical practice. We sought to evaluate...
Autores principales: | Papa, Linda, Brophy, Gretchen M., Alvarez, Wilmer, Hirschl, Robert, Cress, Marshall, Weber, Kurt, Giordano, Philip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363108/ https://www.ncbi.nlm.nih.gov/pubmed/37481589 http://dx.doi.org/10.1038/s41598-023-38804-4 |
Ejemplares similares
-
Assessment of Serum UCH-L1 and GFAP in Acute Stroke Patients
por: Ren, Changhong, et al.
Publicado: (2016) -
Evaluating glial and neuronal blood biomarkers GFAP and UCH-L1 as gradients of brain injury in concussive, subconcussive and non-concussive trauma: a prospective cohort study
por: Papa, Linda, et al.
Publicado: (2019) -
Omega-3 Fatty Acids and Vitamin D Decrease Plasma T-Tau, GFAP, and UCH-L1 in Experimental Traumatic Brain Injury
por: Scrimgeour, Angus G., et al.
Publicado: (2021) -
Study protocol for investigating the performance of an automated blood test measuring GFAP and UCH-L1 in a prospective observational cohort of patients with mild traumatic brain injury: European BRAINI study
por: Richard, Marion, et al.
Publicado: (2021) -
UCH-L1 and GFAP Serum Levels in Neonates with Hypoxic–Ischemic Encephalopathy: A Single Center Pilot Study
por: Douglas-Escobar, Martha V., et al.
Publicado: (2014)